Testis cancer: Rare, but curable with prompt referral

被引：7

作者：

Gilligan, Timothy ^{[1
]}

机构：

[1] Cleveland Clin, Taussig Canc Ctr, Cleveland, OH 44195 USA

来源：

CLEVELAND CLINIC JOURNAL OF MEDICINE | 2007年 / 74卷 / 11期

关键词：

D O I：

10.3949/ccjm.74.11.817

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Testis cancer is rare and rapidly progressive but can almost always be cured. Early detection and prompt treatment by an experienced clinician are the cornerstones of successful management. A delay in diagnosis and inadequate or inappropriate treatment increase the risk of death. The author reviews risk factors, diagnostic features, and current treatment.

引用

页码：817 / 825

页数：9

共 55 条

[41] Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors: The Indiana University experience [J].

Saxman, SB ;

Finch, D ;

Gonin, R ;

Einhorn, LH .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) :702-706

[42] European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG) [J].

Schmoll, HJ ;

Souchon, R ;

Krege, S ;

Albers, P ;

Beyer, J ;

Kollmannsberger, C ;

Fossa, SD ;

Skakkebaek, NE ;

de Wit, R ;

Fizazi, K ;

Droz, JP ;

Pizzocaro, G ;

Daugaard, G ;

de Mulder, PHM ;

Horwich, A ;

Oliver, T ;

Huddart, R ;

Rosti, G ;

Ares, LP ;

Pont, O ;

Hartmann, JT ;

Aass, N ;

Algaba, F ;

Bamberg, M ;

Bodrogi, I ;

Bokemeyer, C ;

Classen, J ;

Clemm, S ;

Culine, S ;

de Wit, M ;

Derigs, HG ;

Dieckmann, KP ;

Flasshove, M ;

del Muro, XG ;

Gerl, A ;

Germa-Lluch, JR ;

Hartmann, M ;

Heidenreich, A ;

Hoeltl, W ;

Joffe, J ;

Jones, W ;

Kaiser, G ;

Klepp, O ;

Kliesch, S ;

Kisbenedek, L ;

Koehrmann, KU ;

Kuczyk, M ;

Laguna, MP ;

Leiva, O ;

Loy, V .

ANNALS OF ONCOLOGY, 2004, 15 (09) :1377-1399

[43] Testicular cancer: perils of very late presentation [J].

Steele, JPC ;

Timothy, R ;

Oliver, D .

LANCET, 2002, 359 (9318) :1632-1633

[44] Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: Impact of patient selection factors on outcome [J].

Stephenson, AJ ;

Bosl, GJ ;

Motzer, RJ ;

Kattan, MW ;

Stasi, J ;

Bajorin, DF ;

Sheinfeld, J .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) :2781-2788

[45] The role of retroperitoneal lymph node dissection in the management of testicular cancer [J].

Stephenson, AJ ;

Sheinfeld, J .

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2004, 22 (03) :225-233

[46]

TESTIS, 2002, AM JOINT COMM CANC, P347

[47] Bilateral germ-cell tumours: 22-year experience at the Institut Gustave Roussy [J].

Theodore, C ;

Terrier-Lacombe, MJ ;

Laplanche, A ;

Benoit, G ;

Fizazi, K ;

Stamerra, O ;

Wibault, P .

BRITISH JOURNAL OF CANCER, 2004, 90 (01) :55-59

[48] Second cancers among 40576 testicular cancer patients:: Focus on long-term survivors [J].

Travis, LB ;

Fosså, SD ;

Schonfeld, SJ ;

McMaster, ML ;

Lynch, CF ;

Storm, H ;

Hall, P ;

Holowaty, E ;

Andersen, A ;

Pukkala, E ;

Andersson, M ;

Kaijser, M ;

Gospodarowicz, M ;

Joensuu, T ;

Cohen, RJ ;

Boice, JD ;

Dores, GM ;

Gilbert, ES .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (18) :1354-1365

[49] Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer [J].

van den Belt-Dusebout, AW ;

Nuver, J ;

de Wit, R ;

Gietema, JA ;

Huinink, WWT ;

Rodrigus, PTR ;

Schimmel, EC ;

Aleman, BMP ;

van Leeuwen, FE .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (03) :467-475

[50] Salvage chemotherapy for patients with advanced pure seminoma [J].

Vuky, J ;

Tickoo, SK ;

Sheinfeld, J ;

Bacik, J ;

Amsterdam, A ;

Mazumdar, M ;

Reuter, V ;

Bajorin, DF ;

Bosl, GJ ;

Motzer, RJ .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) :297-301

← 1 2 3 4 5 6 →